Corteva Förvaltning
Förvaltning kriterier kontrolleras 3/4
Corteva VD är Chuck Magro, utsedd i Nov 2021, har en mandatperiod på 4.58 år. totala årliga ersättningen är $ 17.50M, bestående av 8% lön 92% bonusar, inklusive företagsaktier och optioner. äger direkt 0.03% av företagets aktier, värda $ 16.27M. Den genomsnittliga mandatperioden för ledningsgruppen och styrelsen är 3.8 år respektive 5.3 år.
Viktig information
Chuck Magro
Verkställande direktör
US$17.5m
Total ersättning
| VD-lön i procent | 8.03% |
| Anställning som VD | 4.6yrs |
| Ägande av VD | 0.03% |
| Ledningens genomsnittliga anställningstid | 3.8yrs |
| Styrelsens genomsnittliga mandatperiod | 5.3yrs |
Senaste uppdateringar av ledningen
Recent updates
Analysartikel • Jun 20
Corteva (CTVA) Stock Could Be 13% Undervalued After FMC Herbicide Deal
Why the new FMC partnership matters for Corteva stock Corteva (CTVA) recently signed a multi-year, co-exclusive supply and license agreement with FMC Corporation for rimisoxafen herbicide technology, giving the company another tool in corn and soybean crop protection. The deal covers North and South American markets, includes a US$200 million prepurchase payment from Corteva, and allows both companies to create their own premix formulations. Commercial sales are targeted by the end of the...
Uppdatering av berättelse • Jun 14
CTVA: Upcoming Spin Focused On Seed And Crop Protection Will Reshape Earnings Mix
Corteva's updated analyst price target edges higher by about $0.14 to roughly $90.05, as analysts refine their assumptions around revenue growth, profit margins and future P/E in light of recent target increases across the Street for the upcoming spin focused on seed and crop protection businesses. Analyst Commentary Recent research updates around Corteva cluster around the upcoming spin of its seed and crop protection businesses, with a series of higher price targets reflecting refreshed views on growth, execution and valuation for what some refer to as "New Corteva." Bullish analysts point to recalibrated assumptions on revenue, margins and P/E, while more cautious voices focus on whether the standalone company can consistently deliver against those expectations once separated.Uppdatering av berättelse • May 31
CTVA: SpinCo Separation And Biofungicide Collaboration Will Reshape Future Earnings Mix
The analyst price target for Corteva is updated to $89.90 from $86.05 as analysts note that the market is treating "New Corteva" like a no-growth commodity chemical company. They instead highlight expectations for a healthier standalone growth profile, modestly higher profit margins, and a slightly lower assumed future P/E multiple.Seeking Alpha • May 28
Corteva: Two Businesses, One Price
Summary Corteva, Inc. (CTVA) is rated Hold due to valuation concerns ahead of its planned separation into Vylor (Seed) and New Corteva (Crop Protection). DCF analysis implies a share price of $51.95, significantly below the current market price, while SOTP multiples suggest higher value, primarily from Vylor's premium profile. Seed/Vylor is higher-margin and more defensible, while Crop Protection/New Corteva faces cyclical and competitive pressures, impacting future standalone multiples. Key risks include execution of the separation, realization of valuation premiums, and segment-specific challenges such as Vylor's market share and New Corteva's pricing pressure. Read the full article on Seeking AlphaAnalysartikel • May 14
Corteva's (NYSE:CTVA) Performance Is Even Better Than Its Earnings Suggest
Even though Corteva, Inc.'s ( NYSE:CTVA ) recent earnings release was robust, the market didn't seem to notice...Uppdatering av berättelse • Apr 27
CTVA: Fair Value View Weighs Crop Protection Uncertainty And Planned SpinCo Separation
Corteva's analyst price target has increased by about $2, as analysts cite updated earnings models, a revised fair value of $86.05, a slightly adjusted discount rate, and modest changes to revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Street research on Corteva has been active, with several price target revisions and a mix of ratings changes that give you both supportive and cautious signals to weigh.Uppdatering av berättelse • Apr 13
CTVA: Fair Value View Balances Crop Protection Risks And Upcoming SpinCo Separation
The analyst price target for Corteva has moved modestly higher to align with a fair value estimate of about $84, as analysts factor in updated earnings models, slightly adjusted revenue growth and profit margin assumptions, and recent price target changes across several firms. Analyst Commentary Recent Street research on Corteva shows a mix of higher price targets and a few rating downgrades, so you are seeing both optimism and caution reflected in the current analyst debate.Uppdatering av berättelse • Mar 28
CTVA: Crop Protection Uncertainty And SpinCo Separation Will Shape Future Risk Balance
The analyst price target for Corteva has been nudged higher, with a modest fair value uplift to $83.95 as analysts balance a series of recent target increases from multiple firms against more cautious views tied to softer crop protection trends. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on near term fundamentals, especially in crop protection.Uppdatering av berättelse • Mar 12
CTVA: Mixed Crop Protection Outlook And New SpinCo Plan Will Shape Risk Balance
The analyst price target for Corteva edges higher to $83.33 from $82.76, as analysts factor in slightly firmer long term revenue growth and profit margins, while balancing more cautious views on crop protection trends and a modestly lower discount rate. Analyst Commentary Recent research on Corteva reflects a split view, with several firms lifting price targets while others turn more cautious on execution in crop protection.Uppdatering av berättelse • Feb 26
CTVA: Sector Uncertainty And New Ventures Will Shape Forward Risk Balance
Corteva's analyst fair value estimate has edged up to $82.76 from $82.05 as analysts refine their models and price targets following recent earnings updates and a broad wave of upward target revisions across the Street. Analyst Commentary Recent Street research around Corteva reflects an active debate, with several firms adjusting price targets and a mix of upgrades and downgrades around the latest earnings update.Uppdatering av berättelse • Feb 11
CTVA: Mixed Sector Backdrop And New Ventures Will Shape Future Prospects
Corteva's analyst fair value estimate has increased to $82.05 from $78.43 as analysts factor in slightly stronger revenue growth assumptions, a higher future P/E multiple, and a modestly lower discount rate, even as projected profit margins are trimmed. Analyst Commentary Recent Street research on Corteva is mixed, with several bullish analysts lifting price targets while a few high profile firms turn more cautious.Uppdatering av berättelse • Jan 26
CTVA: Seed And Crop Protection Split Will Shape Balanced Future Prospects
Narrative Update Analysts have modestly raised their price expectations for Corteva, with the updated fair value estimate moving by about US$0.48 per share. This reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E, and is supported by recent target increases from several firms.Uppdatering av berättelse • Jan 11
CTVA: Planned Seed And Pesticide Split Will Support Future Earnings Power
Analysts lifted their blended fair value estimate for Corteva by about $0.19 to roughly $77.95 per share, reflecting updated price targets that factor in a mixed backdrop for chemicals and agriculture but continued confidence in the company’s ability to increase earnings. Analyst Commentary Recent research on Corteva reflects a mix of optimism and caution, with price targets clustered in the mid to high US$70s and one outlier in the low US$80s.Uppdatering av berättelse • Dec 18
CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power
The analyst price target for Corteva has been nudged higher by approximately $0.05 to about $77.76, as analysts factor in a slightly lower discount rate and modestly improved long term growth expectations, despite broadly cautious sector commentary and recent target reductions. Analyst Commentary Street research on Corteva reflects a divided but generally constructive view, with price targets drifting lower but ratings remaining skewed toward positive as investors reassess the company’s post breakup trajectory and near term earnings backdrop.Uppdatering av berättelse • Dec 03
CTVA: Planned Seed And Pesticide Split Will Unlock Future Earnings Power
Our analyst price target for Corteva has been trimmed modestly in line with recent Street moves, as analysts factor in lower sector multiples and near term earnings uncertainty around the planned split, while still recognizing the company’s intact innovation engine and long term earnings growth potential. Analyst Commentary Street views on Corteva have become more bifurcated following the announced split, with valuation targets reset lower but ratings broadly supportive of the long term strategic rationale and earnings power.Analysartikel • Nov 26
A Look At The Fair Value Of Corteva, Inc. (NYSE:CTVA)
Key Insights Corteva's estimated fair value is US$63.85 based on 2 Stage Free Cash Flow to Equity Current share price...Uppdatering av berättelse • Nov 19
CTVA: Upcoming Seed And Pesticide Split Will Unlock Shareholder Value
The analyst consensus price target for Corteva has been modestly reduced, slipping from approximately $77.86 to $77.71. Analysts reflect more cautious expectations for earnings growth in light of a mixed agricultural outlook and anticipated impacts from the company's planned business split.Uppdatering av berättelse • Nov 05
CTVA: Share Split Will Drive Shareholder Value Unlocking Amid Ongoing Business Realignment
Analysts have modestly reduced their average price target for Corteva by approximately $1.20. They cite a more cautious outlook amid challenging crop protection conditions and the company's recent announcement to split into two separate businesses.Uppdatering av berättelse • Oct 22
Analysts Offer Mixed Views as Corteva Eyes Split and Updates Guidance Amid Modest Valuation Shift
Analysts have modestly reduced their price target for Corteva by about $0.76 to $79.05. They cite uncertainty regarding the company’s planned split and the retention of legacy liabilities, though fundamentals and growth remain largely stable.Uppdatering av berättelse • Oct 08
High-Yield Seed Demand And Eco Policies Will Transform Agriculture
Corteva's analyst price target has been modestly reduced by $0.95 per share. Analysts cite continued uncertainty around the planned corporate split and complex crop protection market dynamics.Uppdatering av berättelse • Sep 04
High-Yield Seed Demand And Eco Policies Will Transform Agriculture
Analysts maintained their price target for Corteva at $80.76, citing margin expansion and EBITDA growth driven by successful innovation, favorable market fundamentals, and strong execution. Analyst Commentary Ongoing cost reductions, successful innovation, and strong execution are driving margin expansion and double-digit EBITDA growth.Analysartikel • Aug 26
Corteva's (NYSE:CTVA) Shareholders Will Receive A Bigger Dividend Than Last Year
Corteva, Inc. ( NYSE:CTVA ) will increase its dividend from last year's comparable payment on the 15th of September to...Analysartikel • Aug 01
Corteva's (NYSE:CTVA) Shareholders Will Receive A Bigger Dividend Than Last Year
Corteva, Inc. ( NYSE:CTVA ) will increase its dividend on the 15th of September to $0.18, which is 5.9% higher than...Analysartikel • Jul 28
Investors Interested In Corteva, Inc.'s (NYSE:CTVA) Earnings
With a price-to-earnings (or "P/E") ratio of 43.9x Corteva, Inc. ( NYSE:CTVA ) may be sending very bearish signals at...Analysartikel • Jul 14
We Think Corteva (NYSE:CTVA) Can Stay On Top Of Its Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Seeking Alpha • Apr 21
Corteva: Upgraded To Strong Buy On Tariffs, Currency Tailwinds, Strong Guidance
Summary Upgrading Corteva from Buy to Strong Buy due to macro conditions, including tariff-induced supply shocks, rising commodity prices, and currency tailwinds. Corteva's diversified supply chain and local production in seeds position it to benefit from regionalization and potential inflationary pressures in the agricultural sector. Strong Q4 earnings, record operating EBITDA margin, and robust free cash flow support the bullish outlook, with significant shareholder returns through dividends and buybacks. Improved valuation at 20x forward earnings, solid balance sheet, and technical indicators suggest potential for further upside in the current market environment. Read the full article on Seeking AlphaSeeking Alpha • Mar 30
Pure Market Inefficiency In Corteva Preferreds Pricings
Summary This article explores a market inefficiency in fixed-income securities, specifically between Corteva's $4.50 and $3.50 Series Cumulative Preferred Stocks. We identified an arbitrage opportunity due to technical buying, making it an ideal pair trade with identical issues from the same company. On 02/09/2025, we recommended CTA-B for our investment-grade long-duration portfolio. On 02/10/2025, technical high-volume buying in CTA-A turned our initial investment idea into a pair trade. This pair trade highlights how technical factors can create profitable opportunities in fixed-income securities, especially among identical issues from the same issuer. Read the full article on Seeking AlphaSeeking Alpha • Feb 09
CTA.PR.B: An Undervalued Investment-Grade Opportunity From Corteva
Summary CTA-B offers a 6.32% current yield, making it an attractive investment-grade preferred stock with solid financial backing from Corteva, Inc. Corteva, Inc.'s strong financial health and low leverage ensure the safety of uninterrupted dividend distributions for CTA-B shareholders. Comparative analysis shows CTA-B is undervalued, offering a potential 10% capital appreciation relative to its peers and Corteva's OTC bonds. Corteva's BBB credit rating and low-risk perception in the bond market further reinforce the security and value of investing in CTA-B. Read the full article on Seeking AlphaSeeking Alpha • Jan 10
Corteva: A Wide-Moat Play On Commodity Prices
Summary Corteva is a strong defensive play for stagflation with its wide economic moat in seeds, providing exposure to agricultural commodities and a growing dividend. The company has shown impressive performance since its 2019 spin-off, with growth in gross profits and operating income exceeding revenue growth, reflecting strong operating efficiency. Corteva faces risks such as regulatory and ESG concerns, pricing pressure in crop protection, and currency fluctuations, but remains a resilient and diversified investment. I rate Corteva a "Buy" for its defensive characteristics, allowing investors to gain commodity exposure as a best-in-breed operator. Read the full article on Seeking AlphaAnalys av ersättningar till VD
| Datum | Total ersättning | Lön | Företagets resultat |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$1b |
| Dec 31 2025 | US$17m | US$1m | US$1b |
| Sep 30 2025 | n/a | n/a | US$2b |
| Jun 30 2025 | n/a | n/a | US$1b |
| Mar 31 2025 | n/a | n/a | US$1b |
| Dec 31 2024 | US$15m | US$1m | US$851m |
| Sep 30 2024 | n/a | n/a | US$670m |
| Jun 30 2024 | n/a | n/a | US$874m |
| Mar 31 2024 | n/a | n/a | US$698m |
| Dec 31 2023 | US$13m | US$1m | US$929m |
| Sep 30 2023 | n/a | n/a | US$1b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$15m | US$1m | US$1b |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$2m | US$255k | US$2b |
Ersättning vs marknad: Chuck s total kompensation ($USD 17.50M ) är ungefär genomsnittet för företag av liknande storlek på US marknaden ($USD 14.67M ).
Ersättning vs inkomst: Ersättningen för Chuck har ökat med mer än 20 % det senaste året.
VD OCH KONCERNCHEF
Chuck Magro (56 yo)
4.6yrs
Anställning
US$17,499,399
Kompensation
Mr. Charles Victor Magro, also known as Chuck, B.Sc. (Chem), MBA serves as Chief Executive Officer and Director for Corteva, Inc. since November 1, 2021. He is Chief Executive Officer and Director of EIDP,...
Ledningsgrupp
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| CEO & Director | 4.6yrs | US$17.50m | 0.030% $ 16.3m | |
| Executive VP & CFO | 1.8yrs | US$4.48m | 0.012% $ 6.6m | |
| Executive VP and Chief Technology & Digital Officer | 5.4yrs | US$3.77m | 0.013% $ 7.2m | |
| Senior VP & Strategic Advisor | no data | US$3.56m | 0.015% $ 8.1m | |
| Executive Vice President of Seed Business Unit | 1.5yrs | US$3.21m | 0.0078% $ 4.2m | |
| Executive Vice President of Crop Protection Business Unit | 4.2yrs | US$3.75m | 0.0072% $ 3.8m | |
| VP, Controller & Principal Accounting Officer | 7.1yrs | inga uppgifter | 0.0015% $ 803.5k | |
| Vice President of Investor Relations | no data | inga uppgifter | inga uppgifter | |
| Senior VP | less than a year | inga uppgifter | 0.0019% $ 1.0m | |
| Senior VP & Chief People Officer | 4.3yrs | inga uppgifter | 0.0052% $ 2.8m | |
| Senior VP & Chief Strategy Officer | 1.4yrs | inga uppgifter | inga uppgifter | |
| Senior VP & President of Corteva Asia-Pacific | 3.5yrs | inga uppgifter | inga uppgifter |
3.8yrs
Genomsnittlig anställningstid
55yo
Genomsnittlig ålder
Erfaren ledning: CTVA s ledningsgrupp anses vara erfaren ( 3.8 års genomsnittlig anställningstid).
Styrelseledamöter
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| CEO & Director | 4.6yrs | US$17.50m | 0.030% $ 16.3m | |
| Independent Non-Executive Chairman of the Board | 7.1yrs | US$515.91k | 0.0016% $ 846.3k | |
| Independent Director | less than a year | inga uppgifter | 0.00035% $ 187.5k | |
| Independent Director | 5.3yrs | US$315.65k | 0.0021% $ 1.1m | |
| Independent Director | 7yrs | US$336.48k | 0.0031% $ 1.6m | |
| Independent Director | 5.3yrs | US$332.32k | 0.00037% $ 198.2k | |
| Independent Director | 7yrs | US$315.65k | 0.0066% $ 3.5m | |
| Independent Director | 5.3yrs | US$315.65k | 0.0027% $ 1.5m | |
| Independent Director | 7yrs | US$350.65k | 0.00045% $ 241.0k | |
| Independent Director | less than a year | inga uppgifter | 0.00035% $ 187.5k | |
| Independent Director | 5.3yrs | US$340.65k | 0.000070% $ 37.5k | |
| Independent Director | 6.3yrs | US$315.65k | inga uppgifter |
5.3yrs
Genomsnittlig anställningstid
66.5yo
Genomsnittlig ålder
Erfaren styrelse: CTVA s styrelse anses vara erfaren ( 5.3 års genomsnittlig mandatperiod).
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/06/25 22:28 |
| Aktiekurs vid dagens slut | 2026/06/25 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa denna rapport finns på vår Github-sida; vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Corteva, Inc. bevakas av 35 analytiker. 19 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| null null | Argus Research Company |
| Benjamin Theurer | Barclays |
| Aron Ceccarelli | Berenberg |